Fig. 30From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseChemical structures of tricyclic coumarin derivatives C22–C35Back to article page
